Come up with a name for your new list and we'll add to it:
Cartilix raised a round of funding on , . Investors include
De Novo Ventures.
Cartilix is dedicated to developing new biomaterials to treat disease and improve patient well being. The science of tissue repair is rapidly changing the paradigm for the treatment of many diseases. …